AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109. A total of 69 filers reported holding AMPIO PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 1.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $49,000 | -52.4% | 14,413 | -82.0% | 0.09% | -47.0% |
| Q2 2016 | $103,000 | -71.9% | 80,000 | -51.0% | 0.17% | -73.8% |
| Q1 2016 | $367,000 | -48.7% | 163,300 | -20.1% | 0.64% | -39.3% |
| Q4 2015 | $715,000 | +25.9% | 204,300 | +3.9% | 1.05% | +26.5% |
| Q3 2015 | $568,000 | +21.6% | 196,700 | 0.0% | 0.83% | +57.8% |
| Q2 2015 | $467,000 | -50.6% | 196,700 | +56.7% | 0.53% | -53.1% |
| Q1 2015 | $945,000 | +69.7% | 125,500 | -22.8% | 1.12% | +37.5% |
| Q4 2014 | $557,000 | -7.2% | 162,500 | -4.4% | 0.82% | +60.1% |
| Q3 2014 | $600,000 | -42.5% | 170,000 | +36.0% | 0.51% | -41.9% |
| Q2 2014 | $1,044,000 | +42.6% | 125,000 | +8.5% | 0.88% | +35.0% |
| Q1 2014 | $732,000 | – | 115,224 | – | 0.65% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Empery Asset Management, LP | 4,262,409 | $2,430,000 | 5.07% |
| CVI Holdings, LLC | 5,171,896 | $2,948,000 | 0.20% |
| PRIVATE CAPITAL MANAGEMENT LLC | 937,237 | $534,000 | 0.18% |
| CVA Family Office, LLC | 1,137,920 | $649,000 | 0.16% |
| ACT CAPITAL MANAGEMENT, LLC | 291,500 | $166,000 | 0.12% |
| Cypress Capital Management LLC (WY) | 196,775 | $112,000 | 0.09% |
| Willis Investment Counsel | 2,181,840 | $1,244,000 | 0.06% |
| NTB Financial Corp | 146,100 | $83,000 | 0.06% |
| Helen Stephens Group, LLC | 117,222 | $67,000 | 0.05% |
| SRS Capital Advisors, Inc. | 629,172 | $359,000 | 0.05% |